论文部分内容阅读
心脑血管疾病是导致人类死亡的主要原因之一。动脉粥样硬化血栓形成是心脑血管疾病的病理基础,其中血小板激活和聚集在其形成过程中起核心作用。抗血小板治疗有助于减少心脑血管不良事件的发生。本文重点回顾目前临床应用较多的噻氯吡啶类抗血小板药物医学研究。
Cardiovascular and cerebrovascular diseases are one of the major causes of human death. Atherothrombosis is the pathological basis of cardiovascular and cerebrovascular diseases, in which platelet activation and aggregation play a central role in its formation. Antiplatelet therapy can help reduce the incidence of cardiovascular and cerebrovascular events. This review focuses on the current clinical application of more timolypyridinyl antiplatelet drugs medical research.